Dr. Dara Richardson-Heron is a physician by trade and an advocate by choice, who is passionate about leveraging her skills, experience, and expertise to reduce healthcare disparities.
As Pfizer’s chief patient officer, Dr. Richardson-Heron leads Pfizer’s work to advance patientfocused programs and platforms. Her commitment to seek patients’ voices and input helps Pfizer to better respond to patients’ and communities’ needs, with the goal of helping people live longer, healthier and more productive lives.
Before joining Pfizer in 2020, Dr. Richardson-Heron served as the chief engagement officer and scientific executive for the National Institutes of Health’s (NIH) All of Us Research Program. There, she served on the NIH executive leadership team and led outreach efforts to enroll and retain 1 million or more volunteers in a landmark effort to advance innovative health research that may lead to more precise treatment and prevention strategies. Prior to the NIH, she served as chief executive officer at YWCA USA, chief executive officer of the Greater NYC Affiliate of Susan G. Komen for the Cure, national chief medical officer at the United Cerebral Palsy Association, assistant executive director and chief medical officer at United Cerebral Palsy of New York City, and special assistant to the CEO and executive medical director at Consolidated Edison Company of New York, Inc.
Dr. Richardson-Heron holds a doctorate in medicine from New York University’s School of Medicine and a bachelor’s degree in biology from Barnard College.
